Sermorelin Results
Sermorelin results are the gentlest of the GH peptides - tracked mainly through a modest IGF-1 rise and sleep quality. The subtlety makes objective measurement essential.
Why measurement beats a before/after photo
Sermorelin produces a gentle GH-axis response, so the result is easy to over- or under-estimate by feel. A baseline-vs-6-week IGF-1 draw plus a sleep log is how you confirm anything is happening on a compound this mild.
What to track on Sermorelin
A modest rise confirms the GH-axis response.
Deeper sleep + dream changes are common early effects.
Subjective recovery + daytime energy.
Confirm no glucose drift.
Sermorelin timeline: what tends to shift, when
Bedtime dosing means sleep changes (vivid dreams, depth) often show first.
IGF-1 reaches a modest new set point - confirm with a draw.
Gentle sleep + recovery benefits hold if the response is real.
Signal vs placebo: how to tell a real result
Sermorelin is the mildest GH peptide, so placebo is the biggest risk. The objective read is the IGF-1 baseline-vs-6-week move; the semi-objective read is a wearable sleep-depth trend. If neither moved, "feeling more rested" is probably not the compound.
How to actually track Sermorelin results
Pull IGF-1 at baseline and 6 weeks to confirm the gentle response is real. Log sleep nightly (it is bedtime-dosed, so sleep is the primary felt effect) and note daytime energy. On a compound this subtle, that data is the only honest before/after.
Track Sermorelin results with MyProtocolStack →